Co-overexpression of fibroblast growth factor 3 and epidermal growth factor receptor is correlated with the development of nonsmall cell lung carcinoma

Cancer

Volumn 106, Issue 1, 2006, Pages 146-155

  Tai, Amy L S ^a   Sham, Jonathan S T ^a   Xie, Dan ^b   Fang, Yan ^b   Wu, Yi Long ^c   Hu, Liang ^a   Deng, Wen ^a   Tsao, George S W ^a   Qiao, Gui Bin ^c   Cheung, Annie L M ^a   Guan, Kin Yuan ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^c GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

Epidermal growth factor receptor; Fibroblast growth factor 3; Nonsmall cell lung carcinoma; Tissue microarray

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; FIBROBLAST GROWTH FACTOR 3; GENE PRODUCT; FGF3 PROTEIN, HUMAN; TELOMERASE;

ADULT; ARTICLE; CASE REPORT; CELL STRAIN SCC35; CHROMOSOME 11Q; CHROMOSOME 7P; CHROMOSOME MICRODISSECTION; COMPARATIVE GENOMIC HYBRIDIZATION; CORRELATION ANALYSIS; CYTOPLASM; DISEASE MODEL; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE FUNCTION; GENE OVEREXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; KARYOTYPING; LUNG CARCINOGENESIS; LUNG NON SMALL CELL CANCER; MALE; NORTHERN BLOTTING; PRIORITY JOURNAL; SOUTHERN BLOTTING; TISSUE MICROARRAY; TUMOR CELL LINE; CHROMOSOME 11; CHROMOSOME 7; GENETICS; LUNG TUMOR; METABOLISM; MIDDLE AGED; NON SMALL CELL LUNG CANCER; SPECTRAL KARYOTYPING; SQUAMOUS CELL CARCINOMA;

CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 7; FIBROBLAST GROWTH FACTOR 3; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; RECEPTOR, EPIDERMAL GROWTH FACTOR; SPECTRAL KARYOTYPING; TELOMERASE; TISSUE ARRAY ANALYSIS;

EID: 29744456389     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.21581     Document Type: Article

References (45)

1. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1996. CA Cancer J Clin. 1996;46:5-27.
2. Jemal A, Chu KC, Tarone RE. Recent trends in lung cancer mortality in the United States. J Natl Cancer Inst. 2001;93:277-283.
3. Ginsberg RJ, Kris MG, Armstrong JM. Cancer of the lung. In: Devita VT, Hellman S, Rosenberg SA, editors. Cancer: Principles and practice of oncology, Philadelphia: JB Lippincott, 1993:673-722.
4. Bjorkqvist AM, Husgafvel-Pursiainen K, Anttila S, et al. DNA gains in 3q occur frequently in squamous cell carcinoma of the lung, but not in adenocarcinoma. Genes Chromosomes Cancer. 1998;22:79-82.
5. Petersen S, Aninat-Meyer M, Schluns K, et al. Chromosomal alterations in the clonal evolution to the metastatic stage of squamous cell carcinomas of the lung. Br J Cancer. 2000;82:65-73.
6. Pei J, Balsara BR, Li W, et al. Genomic imbalances in human lung adenocarcinomas and squamous cell carcinomas. Genes Chromosomes Cancer. 2001;31:282-287.
7. Chujo M, Noguchi T, Miura T, et al. Comparative genomic hybridization analysis detected frequent overrepresentation of chromosome 3q in squamous cell carcinoma of the lung. Lung Cancer. 2002;38:23-29.
8. Tai AL, Yan WS, Fang Y, Xie D, Sham JS, Guan XY. Recurrent chromosomal imbalances in nonsmall cell lung carcinoma: the association between 1q amplification and tumor recurrence. Cancer. 2004;100:1918-1927.
9. Guan XY, Fang Y, Sham JST, et al. Recurrent chromosome alterations in hepatocellular carcinoma detected by comparative genomic hybridization. Genes Chromosomes Cancer. 2000;29:110-116.
10. ISCN. Guidelines for cancer cytogenetics. In: Mitelman F, editor. Supplement to International System for Human Cytogenetic Nomenclature. Basel: S. Karger, 1991.
11. Deng W, Tsao SW Guan XY, et al. Distinct profiles of critically short telomeres are a key determinant of different chromosome aberrations in immortalized human cells: whole-genome evidence from multiple cell lines. Oncogene. 2004;23:9090-9101.
12. Guan XY, Trent JM, Meltzer PS. Generation of band-specific painting probes from a single microdissected chromosome. Hum Mol Genet. 1993;2:1117-1121.
13. Xie D, Sham JS, Zeng WF, et al. Heterogenous expressions and associations of β-catenin, p16, E-cadherin, and C-myc in multistage colorectal carcinogenesis and progression. Int J Cancer. 2003;107:896-902.
14. Petersen I, Bujard M, Petersen S, et al. Patterns of chromosomal imbalances in adenocarcinoma and squamous cell carcinoma of the lung. Cancer Res. 1997;57:2331-2335.
15. Brass N, Racz A, Heckel D, Remberger K, Sybrecht GW, Meese EU. Amplification of the genes BCHE and SLC2A2 in 40% of squamous cell carcinoma of the lung. Cancer Res. 1997;57:2290-2294.
16. Massion PP, Kuo WL, Stokoe D, et al. Genomic copy number analysis of non-small cell lung cancer using array comparative genomic hybridization: implications of the phosphatidylinositol 3-kinase pathway. Cancer Res. 2002;62:3636-3640.
17. Guan XY, Sham JS, Tang TC, Fang Y, Huo KK, Yang JM. Isolation of a novel candidate oncogene within a frequently amplified region at 3q26 in ovarian cancer. Cancer Res. 2001;61:3806-3809.
18. Barch MJ, Knutsen T, Spurbeck JL. The AGT cytogenetics laboratory manual, 3rd ed. New York: Lippincott-Raven, 1997.
19. Sibilia M, Wagner EF. Strain-dependent epithelial defects in mice lacking the EGF receptor. Science. 1995;269:234-23824.
20. Threadgill DW, Dlugosz AA, Hansen LA, et al. Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype. Science. 1995;269:230-234.
21. Sibilia M, Fleischmann A, Behrens A, et al. The EGF receptor provides an essential survival signal for SOS-dependent skin tumor development. Cell. 2000;102:211-220.
22. Pai R, Soreghan B, Szabo IL, Pavelka M, Baatar D, Tarnawski AS. Prostaglandin E2 transactivates EGF receptor, a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy. Nat Med. 2002;8:289-293.
23. Sekine I, Takami S, Guang SG, et al. Role of epidermal growth factor receptor overexpression, K-ras point mutation and c-myc amplification in the carcinogenesis of non-small cell lung cancer. Oncol Rep. 1998;5:351-354.
24. Reissmann PT, Koga H, Figlin RA, Holmes EC, Slamon DJ. Amplification and overexpression of the cyclin D1 and epidermal growth factor receptor genes in non-small-cell lung cancer. Lung Cancer Study Group. J Cancer Res Clin Oncol. 1999;125:61-70.
25. Abdollahi A, Bao R, Hamilton TC. LOT1 is a growth suppressor gene down-regulated by the epidermal growth factor receptor ligands and encodes a nuclear zinc-finger protein. Oncogene. 1999;18:6477-6487.
26. Onn A, Correa AM, Gilcrease M, et al. Synchronous overexpression of epidermal growth factor receptor and HER2-neu protein is a predictor of poor outcome in patients with stage I non-small cell lung cancer. Clin Cancer Res. 2004;10:136-143.
27. Swinson DE, Cox G, O'Byrne KJ. Coexpression of epidermal growth factor receptor with related factors is associated with a poor prognosis in non-small-cell lung cancer. Br J Cancer. 2004;91:1301-1307.
28. Alroy I, Yarden Y. The ErbB signaling network in embryo-genesis and oncogenesis: signal diversification through combinatorial ligand-receptor interactions. FEBS Lett. 1997;410:83-86.
29. Vivanco I, Sawyers CL. The phosphatidylinositol 3-kinase AKT pathway in human cancer. Nat Rev Cancer. 2002;2:489-501.
30. Sithanandam G, Smith GT, Masuda A, Takahashi T, Anderson LM, Fornwald LW. Cell cycle activation in lung adenocarcinoma cells by the ErbB3/ phosphatidylinositol 3-kinase/Akt pathway. Carcinogenesis. 2003;24:1581-1592.
31. Fan CS, Wong N, Leung SF, et al. Frequent c-myc and Int-2 overrepresentations in nasopharyngeal carcinoma. Hum Pathol. 2000;31:169-178.
32. Seki A, Yoshinouchi M, Seki N, Kodama J, Miyagi Y, Kudo T. Detection of c-erbB-2 and FGF-3 (INT-2) gene amplification in epithelial ovarian cancer. Int J Oncol. 2000;17:103-106.
33. Esteller M, Garcia A, Martinez i Palones JM, Cabero A, Reventos J. Detection of c-erbB-2/neu and fibroblast growth factor-3/INT-2 but not epidermal growth factor receptor gene amplification in endometrial cancer by differential polymerase chain reaction. Cancer. 1995;75:2139-2146.
34. Lidereau R, Callahan R, Dickson C, Peters G, Escot C, Ali IU. Amplification of the int-2 gene in primary human breast tumors. Oncogene Res. 1988;2:285-29142.
35. Xu J, Tyan T, Cedrone E, Savaraj N, Wang N. Detection of 11q13 amplification as the origin of a homogeneously staining region in small cell lung cancer by chromosome microdissection. Genes Chromosomes Cancer. 1996;17:172-178.
36. Moore R, Casey G, Brookes S, Dixon M, Peters G, Dickson C. Sequence, topography and protein coding potential of mouse int-2: a putative oncogene activated by mouse mammary tumour virus. EMBO J. 1986;5:919-924.
37. Jakobovits A, Shackleford GM, Varmus HE, Martin GR. Two proto-oncogenes implicated in mammary carcinogenesis, int-1 and int-2, are independently regulated during mouse development. Proc Natl Acad Sci U S A. 1986;83:7806-7810.
38. Wilkinson DG, Bhatt S, McMahon AP. Expression pattern of the FGF-related proto-oncogene int-2 suggests multiple roles in fetal development. Development. 1989;105:131-136.
39. Lee FS, Lane TF, Kuo A, Shackleford GM, Leder P. Insertional mutagenesis identifies a member of the Wnt gene family as a candidate oncogene in the mammary epithelium of int-2/Fgf-3 transgenic mice. Proc Natl Acad Sci U S A. 1995;92:2268-2272.
40. Miyoshi K, Rosner A, Nozawa M, et al. Activation of different Wnt/beta-catenin signaling components in mammary epithelium induces transdifferentiation and the formation of pilar tumors. Oncogene. 2002;21:5548-5556.
41. Lese CM, Rossie KM, Appel BN, et al. Visualization of INT2 and HST1 amplification in oral squamous cell carcinomas. Genes Chromosomes Cancer. 1995;12:288-295.
42. Tsuda T, Tahara E, Kajiyama G, Sakamoto H, Terada M, Sugimura T. High incidence of coamplification of hst-1 and int-2 genes in human esophageal carcinomas. Cancer Res. 1989;49:5505-5508.
43. Kitagawa Y, Ueda M, Ando N, Shinozawa Y, Shimizu N, Abe O. Significance of int-2/hst-1 coamplification as a prognostic factor in patients with esophageal squamous carcinoma. Cancer Res. 1991;51:1504-1508.
44. Taguchi T, Cheng GZ, Bell DW, et al. Combined chromosome microdissection and comparative genomic hybridization detect multiple sites of amplification DNA in a human lung carcinoma cell line. Genes Chromosomes Cancer. 1997;20:208-212.
45. Ooi A, Takehana T, Li X, et al. Protein overexpression and gene amplification of HER-2 and EGFR in colorectal cancers: an immunohistochemical and fluorescent in situ hybridization study. Mod Pathol. 2004;17:895-904.